Skip to main content

Table 3 Potential adverse events and selected laboratory valuesa

From: Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial

  Hydrocortisone (n = 25) Placebo (n = 25) p value
Adverse event after study drug    
 Any bleeding 5 (20 %) 2 (9 %) 0.42
 New or changed antibiotics 9 (36 %) 11 (44 %) 0.77
 New insulin infusion 7 (28 %) 6 (24 %) 1.00
Laboratory values    
 Glucose level (mg/dL)    
  6 hour 242 (151) 230 (118) 0.76
  24 hour 218 (109) 199 (90) 0.54
  48 hour 163 (50) 155 (59) 0.66
  72 hour 150 (52) 144 (61) 0.79
 Sodium level (mmol/L)    
  6 hour 139 (5) 139 (6) 0.78
  24 hour 139 (5) 138 (5) 0.37
  48 hour 139 (7) 139 (5) 0.80
  72 hour 143 (6) 139 (8) 0.09
 White blood count (x 103)    
  6 hour 15.0 (6.9) 17.0 (6.7) 0.43
  24 hour 17.8 (8.7) 15.5 (4.7) 0.29
  48 hour 21.5 (9.3) 12.6 (3.4) <0.001
  72 hour 19.2 (8.8) 11.9 (2.9) 0.005
  1. aCategorical variables are presented as count (frequency) and continues variables as mean (standard deviation)